Cardix

Quick links to important sections

Cardix

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cardix

What is Cardix?

Cardix is a pharmacological treatment classified as a calcium channel blocker. It is primarily used in the management of cardiovascular conditions, specifically hypertension and chronic stable angina. By influencing the movement of calcium ions into the cells of the heart and blood vessels, the medication facilitates a more efficient circulatory process.

Mechanism of Action

The active component in Cardix works by inhibiting the transmembrane influx of calcium ions into cardiac muscle and vascular smooth muscle. This action leads to the relaxation of the arterial muscle walls, which reduces peripheral vascular resistance. As the blood vessels dilate, the heart can pump blood more easily throughout the body, resulting in lower systemic blood pressure.

For patients with angina, Cardix helps by increasing the delivery of oxygen to the myocardial tissue. It achieves this by dilating the main coronary arteries and arterioles, which improves blood flow to the heart muscle and prevents spasms that can lead to chest pain.

Therapeutic Objectives

The primary goals of treatment with Cardix include:

  • Blood Pressure Regulation: Assisting in the long-term management of high blood pressure to reduce the workload on the cardiovascular system.
  • Angina Management: Reducing the frequency of angina attacks and improving exercise tolerance in individuals with documented coronary artery disease.

As a systemic treatment, Cardix is integrated into broader management plans for cardiovascular health, focusing on the physiological stabilization of blood flow and pressure.

What side effects are possible with Cardix?

Possible Side Effects and Safety Information

The safety profile of Cardix, containing Isosorbide Dinitrate, is classified based on official regulatory documents, with adverse reactions largely related to its action as a Nitrate Vasodilator.

Adverse Reaction Classification

Side effects are formally grouped by frequency and the body system affected (System-Organ Class or SOC). The most frequently documented reactions are associated with the nervous and vascular systems:

  • Very Common (ge 1/10): Headache.
  • Common (ge 1/100 to < 1/10): Dizziness, Hypotension (low blood pressure), Tachycardia (fast heart rate), and Orthostatic Hypotension (dizziness on standing).

Less common reactions involve the gastrointestinal system (Nausea, Vomiting) and skin (Flushing, Allergic skin reactions). The regulatory documents classify severe skin reactions, such as Stevens-Johnson syndrome and Angioedema, as Very Rare (lt 1/10,000).

Time-Related Patterns and Serious Reactions

Regulatory information notes that the common Headache often tends to diminish with continued treatment. Conversely, reactions like Hypotension and dizziness are noted to occur particularly at the beginning of treatment or when the dosage is increased. Serious adverse reactions officially documented include Circulatory Collapse and Severe Hypotensive Responses.

Safety Restrictions and Special Populations

Safety labeling explicitly Contraindicates the concomitant use of Cardix with Phosphodiesterase Type 5 (PDE5) inhibitors (e.g., sildenafil) and soluble Guanylate Cyclase (sGC) stimulators due to the significant risk of severe hypotension. Furthermore, official safety considerations advise caution when the medicine is used in specific populations, including older adults and individuals with severe hepatic or renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation defines Cardix (Isosorbide Dinitrate) overdose as a medical emergency resulting from the severe exaggeration of its effects, primarily focusing on extreme hemodynamic instability and systemic oxygen compromise.

Documented Overdose Presentations

An overdose may manifest as a prompt fall in blood pressure (e.g., le90 mmHg), often accompanied by severe tachycardia, vertigo, syncope, and a persistent, throbbing headache. Gastrointestinal symptoms documented in official labeling include nausea, vomiting, and potentially bloody diarrhea.

Severe Outcomes and Required Actions

Severe overexposure can lead to vascular collapse and life-threatening Methemoglobinemia, a condition where oxygen delivery is compromised. Regulators define such severe cases as requiring immediate emergency help. The official instructions mandate support of the cardiovascular system as the primary treatment goal, which includes elevation of the extremities and central volume expansion using intravenous fluids. Patients experiencing a severe acute overdose should be admitted to an intensive care unit for continuous monitoring. While no specific antidote exists for the nitrate itself, Methylene Blue is the specific treatment for documented Methemoglobinemia.

Therapeutic Uses of Cardix

What Cardix Treats: Main Uses and Benefits

Cardix, which contains the active substance diltiazem, is a calcium channel blocker commonly applied across domains where additional symptomatic support is needed for significant cardiovascular conditions. The primary therapeutic areas are relevant in contexts involving heightened systemic burden, specifically for the treatment of hypertension and the management of chronic stable angina.

The medicine is relevant for easing symptoms related to physical discomfort often associated with angina, and assists in addressing symptoms related to systemic imbalance linked to high blood pressure. It is commonly used in situations involving recurrent or episodic manifestations like certain heart arrhythmias, providing supportive relief when symptoms intensify.

The medication plays a role in managing two main conditions characterized by periods of heightened symptoms: hypertension (high blood pressure) and chronic stable angina (chest pain). It provides support that helps ease the overall symptom burden.

“This medication is commonly used to help with conditions marked by increased physiological stress.”

Quick Fact: Applied in Addressing Symptoms that Create Noticeable Physiological Strain

Eligibility and Restrictions for Use

The eligibility for Cardix (Isosorbide Dinitrate) is determined by explicit rules documented by regulatory agencies, strictly defining who may use the medicine and under what conditions. Use is primarily established for Adults (18 years and older).

Contraindicated Populations (Must Not Use)

Use of Cardix is absolutely prohibited (contraindicated) in several groups, most notably:

  • Patients with documented hypersensitivity to any organic nitrate.
  • Patients concurrently receiving Phosphodiesterase Type 5 (PDE5) Inhibitors (e.g., sildenafil) or the Soluble Guanylate Cyclase (sGC) Stimulator riociguat.
  • Patients with marked anaemia, acute circulatory failure, or specific cardiovascular conditions like constrictive pericarditis.

Restricted and Conditional Use

Regulatory labeling defines limitations for certain patient groups:

  • Age: Safety and effectiveness have not been established for pediatric patients. Use in older adults requires caution and careful dosage selection.
  • Organ Function: Caution is required for patients with severe renal impairment or severe hepatic impairment.
  • Reproductive Status: Use during pregnancy and lactation is generally restricted and only permitted if the clear benefit outweighs the potential risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Interaction Profile

The regulatory documentation for Cardix (Isosorbide Dinitrate) strictly defines combinations that are contraindicated due to severe interaction risks, along with substances that may cause additive effects or modify drug levels.

Formal Contraindications (Pharmacodynamic Synergism)

Co-administration with specific pharmacological classes is prohibited based on official regulatory labels due to the potential for severe hypotension.

  • Phosphodiesterase Type 5 (PDE5) Inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil): The co-administration of Cardix is strictly contraindicated.
  • Soluble Guanylate Cyclase (sGC) Stimulators (e.g., Riociguat): Concomitant use is formally prohibited due to the risk of potentiated hypotension.

Timing-Based Administration Rules

Regulatory warnings specify minimum separation times following the use of certain contraindicated medicines before Cardix can be administered:

Contraindicated Medicine Mandatory Time Separation
Sildenafil or Vardenafil At least 24 hours
Tadalafil At least 48 hours

Additive Pharmacodynamic Effects

Other substances are officially documented to cause additive vasodilating effects, which may potentiate hypotensive responses. These include other Antihypertensive Drugs, other Vasodilators, and Alcohol (Ethanol). Additionally, Isosorbide Dinitrate has been reported to increase the blood level of Dihydroergotamine.

Mechanism of Action

Cardix (Isosorbide Dinitrate) exerts its physiological effects by operating through the Nitric Oxide ( NO) signaling pathway to modulate vascular tone, directly resulting in a reduction of cardiac workload.

NO Bioactivation and the cGMP Cascade

The drug functions as a prodrug that is converted by enzymes, such as Mitochondrial Aldehyde Dehydrogenase ( mtALDH), into the active gas extbfNitric Oxide. The NO rapidly activates the enzyme Soluble Guanylyl Cyclase ( sGC), leading to a surge in the intracellular messenger cyclic Guanosine Monophosphate ( cGMP), which drives vascular smooth muscle relaxation.

Modulation of Preload and Afterload

This widespread extbfvasodilation preferentially affects the venous system, causing greater blood pooling and decreasing the blood volume returning to the heart ( extbfPreload). Simultaneously, dilation of the arterial system reduces the resistance against which the heart pumps ( extbfAfterload). This dual action results in a reduction of cardiac workload and decreased myocardial oxygen demand. The drug’s action is subject to Nitrate Tolerance, a limitation where continuous exposure causes the mechanism to be functionally constrained, often due to impaired NO bioactivation or counteraction by the sympathetic nervous system.

Dosage and Administration Information

How to Use Cardix

Cardix, which contains the active substance Isosorbide Dinitrate, is administered via two primary routes for outpatient use: the oral route (swallowed) and the sublingual route (dissolved under the tongue). The medicine is available as an immediate-release tablet, an extended-release tablet, and a sublingual tablet.


Dosing Patterns and Frequency

The oral forms are designated for long-term scheduled use. The typical dosing for immediate-release tablets ranges from 5 mg to 40 mg, taken two or three times daily. The extended-release form is usually taken as 40 mg once per day, potentially increasing up to 160 mg daily. A critical principle for all chronic oral administration is the mandatory nitrate-free interval, which requires at least 14 hours of the day without the medication to maintain pharmacological activity over time.


Administration Instructions

The sublingual tablet (typically 2.5 mg or 5 mg) is used for rapid action, and this form must be placed and allowed to dissolve completely under the tongue; it must not be swallowed or chewed. Conversely, the extended-release oral tablets must be swallowed whole to ensure the intended slow release of the active substance. All oral forms may be taken independently of meals.

For older adults, treatment typically begins at the lower end of the established dosing range through cautious dose selection. If a scheduled dose is missed, the standard procedure is to skip the missed dose entirely and continue with the next scheduled dose; doubling the dose to compensate is not recommended. The safety and usage patterns have not been established for pediatric patients.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cardix (Isosorbide Dinitrate)

Evidence for Use in Stable Angina Pectoris

Research has examined Isosorbide Dinitrate's substance in studies involving stable angina pectoris, a condition characterized by fluctuating or episodic manifestations. The primary research consists of short- to intermediate-term Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies primarily included adult populations and research examined outcomes related to physical discomfort and daily functioning or activity level.

In these trials, researchers monitored outcomes such as the weekly frequency of chest pain episodes and the patient’s ability to exercise. Studies report how symptoms evolved in the observed populations, often describing patterns related to changes observed in the frequency of anginal episodes over the short-term. Studies monitored and described how the time it took for symptoms to appear evolved during a stress test.

Evidence for Use in Chronic Heart Failure

Isosorbide Dinitrate's substance was studied for its potential use in the context of chronic heart failure, a condition marked by functional limitations and high physiological strain. This evidence is largely derived from large-scale, long-term Randomized Controlled Trials (RCTs). Importantly, these pivotal studies primarily examined the substance in a combination regimen with another specific type of blood vessel widening medication.

These trials research examined hard clinical endpoints such as all-cause mortality and rates of hospitalization for worsening heart failure. Research described patterns observed related to long-term survival and hospitalization rates when the substance was observed in a specific combination therapy, particularly in predefined patient subgroups. These findings describe group patterns, not personal outcomes under those specific combination regimens.

Key Uncertainties and Research Gaps

The research base, while substantial in core indications, still contains areas where certainty remains low or data are insufficient. The research includes limited evidence regarding the long-term outcomes of the substance when used alone (monotherapy) for most cardiovascular conditions. The existing body of research results apply only to the populations studied and the specific conditions under which the trials were conducted.

Furthermore, the evidence base includes documented findings related to a phenomenon known as nitrate tolerance, where studies observed a temporary decrease in the drug's activity over time. This challenge means that research exploring short-term symptom changes provides context but not individual predictions for sustained, continuous use.

Frequently Asked Questions (FAQ)

Common questions about Cardix (FAQ)

Q: How quickly does Cardix start to work?

A: The time it takes for Cardix to start working depends on the form taken. The sublingual tablet (dissolved under the tongue) is designed for a rapid onset of action. In contrast, the standard oral tablet works more slowly, and the extended-release form is specifically designed to provide a sustained therapeutic effect for maintenance use over time.

Q: Is it normal to feel tired when first starting Cardix?

A: Official information lists side effects like dizziness and low blood pressure (hypotension) as common reactions, particularly when treatment begins. While tiredness itself is not a primary common side effect, official information indicates that symptoms associated with low blood pressure, such as feeling unusually weak or tired, are possible.

Q: How long does the effect of Cardix last after I take it?

A: The duration of the effect is related to the specific tablet form. The sublingual tablet has a relatively short duration. The oral tablet lasts longer, and the extended-release version is formulated to provide a prolonged, sustained effect to help maintain the treatment over many hours.

Q: Does Cardix affect sleep?

A: Regulatory documents primarily list adverse reactions related to the vascular and nervous systems, such as headache and dizziness. Sleep disturbances or insomnia are not typically listed among the most common adverse reactions in official labeling. It is suggested to communicate any new or bothersome sleep issues to a prescriber.

Q: Can I drink alcohol while taking Cardix?

A: Official regulatory warnings state that alcohol (ethanol) can cause additive vasodilating effects (further widening of blood vessels). This combination may increase the risk of severe hypotension (low blood pressure), which can lead to symptoms like dizziness or fainting.

Q: Does Cardix cause weight gain or loss?

A: Changes in body weight are not listed as common adverse reactions in the official drug labeling. The drug's primary action has been discussed in some research contexts related to fluid dynamics, but weight change is not a common side effect listed in official documents.

Q: Does Cardix cause issues with blood sugar levels?

A: Current regulatory documentation and clinical studies do not indicate that this medicine significantly alters plasma glucose or insulin levels or otherwise affects glucose metabolism in otherwise healthy individuals.

Q: Are there long-term side effects associated with Cardix use?

A: Official documents describe the phenomenon of nitrate tolerance, where the drug's effectiveness can temporarily lessen with continuous exposure over time. For this reason, official labeling also advises against abruptly stopping treatment, recommending a gradual withdrawal process to prevent a potential rebound effect or worsening of symptoms.

Q: Why is Cardix sometimes described as a 'novel' treatment?

A: Cardix contains an organic nitrate, a class of drug whose function—releasing nitric oxide to relax and widen blood vessels—was viewed historically as a significant pharmacological advance. This mechanism established a new category of cardiovascular medicine for managing vascular tone.

Q: Is there a generic version of Cardix available?

A: Yes, the active substance in Cardix is Isosorbide Dinitrate. This compound is commonly available as a prescription generic medication in various countries.

Q: Is Cardix addictive?

A: This medication is not classified as a controlled substance and does not carry warnings related to abuse or addiction liability like narcotic pain medications do. However, official labeling recommends a gradual withdrawal when discontinuing therapy, which is a common practice for many medications.

Q: What should I do if a side effect seems mild?

A: Official patient information directs users to monitor side effects closely. For certain common effects, such as a headache, the labeling notes these often tend to diminish with continued treatment. Official patient information indicates that any side effect that is severe, does not go away, or becomes bothersome is typically communicated to a healthcare provider.

Q: Why are there warnings about certain pre-existing conditions and Cardix?

A: Warnings are in place because the drug’s primary action is to cause widespread vasodilation (widening of blood vessels), which carries a significant risk of severe hypotension (low blood pressure). The medicine is contraindicated (prohibited) for people with specific heart conditions or those who are already prone to very low blood pressure to prevent severe complications.

Q: Has Cardix been studied in children?

A: Official regulatory documents explicitly state that the safety and effectiveness of this medicine have not been established for pediatric patients (children).

Q: Why do doctors prescribe Cardix for some people but not others?

A: Prescribing decisions are based strictly on the drug’s established therapeutic uses (indications) and its official contraindications. For example, the medicine is prohibited for people taking certain other medications or for those with specific pre-existing heart conditions, which limits the population eligible for treatment.

Q: Can I take Cardix if I have a history of depression?

A: A history of depression is not typically listed as an absolute prohibition in standard official prescribing information. However, official guidance suggests that individuals with any psychiatric history communicate all conditions with their healthcare provider, as rare adverse psychiatric reactions, such as hallucinations, have been documented in reports.

Q: Is the research on Cardix still ongoing?

A: Yes, research is still ongoing. Clinical trials registries and published reports show continued investigation into the drug's use, especially in combination therapies for specific conditions like chronic heart failure and to explore its effects on various other cardiovascular issues.

How should Cardix be stored and disposed of?

Storage Conditions

Cardix (Isosorbide Dinitrate) must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be protected from excessive heat and moisture and should not be frozen to maintain product stability. Tablets should be kept in their original container, which must be tightly closed when not in use.

Handling and Child Safety

To comply with regulatory requirements, the medication must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Cardix should be disposed of via an official drug take-back program if one is available. If not, the tablets must be mixed with an unappealing substance, placed in a sealed bag, and discarded in the household trash. The drug should not be flushed down the toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cardix found in:

A-Z Index: